Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Medical Student Perspectives on a Multi-institutional Clerkship Curriculum: A Report From the Radiation Oncology Education Collaborative Study Group.

Ye JC, Mohindra P, Spektor A, Krishnan MS, Chmura SJ, Howard AR, Viswanathan AN, MacDonald SM, Thaker NG, Das P, Mancini BR, Higgins SA, Braunstein S, Haas-Kogan D, Bradley KA, Hung AY, Thomas CR Jr, Kharofa J, Wheatley M, Currey A, Parashar B, Du K, Jimenez RB, Golden DW.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):217-9. doi: 10.1016/j.ijrobp.2015.01.043. No abstract available.

PMID:
25968822
2.

Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma.

Park HS, Ratner ES, Lucarelli L, Polizzi S, Higgins SA, Damast S.

Brachytherapy. 2015 Apr 14. pii: S1538-4721(15)00418-3. doi: 10.1016/j.brachy.2015.03.001. [Epub ahead of print]

PMID:
25887343
3.

High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma.

Damast S, Higgins SA, Ratner E, De Leon MC, Mani S, Silasi DA, Azodi M, Santin A, Rutherford T, Schwartz PE.

J Contemp Brachytherapy. 2015 Feb;7(1):35-40. doi: 10.5114/jcb.2015.48539. Epub 2015 Jan 26.

4.

Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.

Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Damast S.

Int J Gynecol Cancer. 2015 Mar;25(3):431-9. doi: 10.1097/IGC.0000000000000376.

PMID:
25621409
5.

Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation.

Evans SB, Panigrahi B, Northrup V, Patterson J, Baldwin DE, Higgins SA, Moran MS.

Pract Radiat Oncol. 2013 Apr-Jun;3(2):e55-60. doi: 10.1016/j.prro.2012.06.007. Epub 2012 Jul 24.

PMID:
24674321
6.

Phase I clinical trial of the mammalian target of rapamycin inhibitor everolimus in combination with oral topotecan for recurrent and advanced endometrial cancer.

Acevedo-Gadea C, Santin AD, Higgins SA, Urva S, Ratner E, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Abu-Khalaf MM.

Int J Gynecol Cancer. 2014 Mar;24(3):528-33. doi: 10.1097/IGC.0000000000000085.

PMID:
24557436
7.

Radiation therapy and expander-implant breast reconstruction: an analysis of timing and comparison of complications.

Lentz R, Ng R, Higgins SA, Fusi S, Matthew M, Kwei SL.

Ann Plast Surg. 2013 Sep;71(3):269-73. doi: 10.1097/SAP.0b013e3182834b63.

PMID:
23788143
8.

Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?

Bai HX, Motwani SB, Higgins SA, Haffty BG, Wilson LD, Lannin DR, Evans SB, Moran MS.

Int J Clin Oncol. 2014;19(3):460-6. doi: 10.1007/s10147-013-0575-0. Epub 2013 Jun 19.

PMID:
23780727
9.

Intraoperative radiotherapy for breast cancer: deceptively simple?

Evans SB, Higgins SA.

Oncology (Williston Park). 2013 Feb;27(2):122, 124. No abstract available.

10.

Does the left hand know what the right hand is doing? What plastic surgeons need to know about radiation therapy techniques.

Lentz RB, Craig ES, Ross CC, Fusi S, Higgins SA.

Plast Reconstr Surg. 2012 Nov;130(5):772e-773e. doi: 10.1097/PRS.0b013e318267da92. No abstract available.

PMID:
23096658
11.

Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy.

Rockwell S, Grove TA, Liu Y, Cheng YC, Higgins SA, Booth CJ.

Int J Radiat Biol. 2013 Jan;89(1):16-25. doi: 10.3109/09553002.2012.717733. Epub 2012 Sep 3.

12.

A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer.

Moran MS, Ma S, Jagsi R, Yang TJ, Higgins SA, Weidhaas JB, Wilson LD, Lloyd S, Peschel R, Gaudreau B, Rockwell S.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):40-6. doi: 10.1016/j.ijrobp.2012.03.025. Epub 2012 Jun 1.

PMID:
22658441
13.

Using nodal ratios to predict risk of regional recurrences in patients treated with breast conservation therapy with 4 or more positive lymph nodes.

Castrucci W, Lannin D, Haffty BG, Higgins SA, Moran MS.

ISRN Surg. 2011;2011:874814. doi: 10.5402/2011/874814. Epub 2011 Jun 30.

14.

Management of cellulitis associated with treatment of breast cancer.

Milgrom S, Higgins SA.

J Support Oncol. 2009 Sep-Oct;7(5):174-6. Review. No abstract available.

PMID:
19831161
15.

Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes.

Moran MS, Castrucci WA, Ahmad M, Song H, Lund MW, Mani S, Chamberlain D, Higgins SA.

Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1026-36. doi: 10.1016/j.ijrobp.2009.02.066.

PMID:
19596174
16.

Brain metastases in epithelial ovarian and primary peritoneal carcinoma.

Ratner ES, Toy E, O'Malley DM, McAlpine J, Rutherford TJ, Azodi M, Higgins SA, Schwartz PE.

Int J Gynecol Cancer. 2009 Jul;19(5):856-9. doi: 10.1111/IGC.0b013e3181a83301.

PMID:
19574773
17.

Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter.

Christy CJ, Thorsteinsson D, Grube BJ, Black D, Abu-Khalaf M, Chung GG, DiGiovanna MP, Miller K, Higgins SA, Weidhaas J, Harris L, Tavassoli FA, Lannin DR.

Ann Surg Oncol. 2009 Mar;16(3):697-702. doi: 10.1245/s10434-008-0268-5. Epub 2009 Jan 9.

PMID:
19132447
18.

Breast sentinel lymph node dissection before preoperative chemotherapy.

Grube BJ, Christy CJ, Black D, Martel M, Harris L, Weidhaas J, Digiovanna MP, Chung G, Abu-Khalaf MM, Miller KD, Higgins SA, Philpotts L, Tavassoli FA, Lannin DR.

Arch Surg. 2008 Jul;143(7):692-9; discussion 699-700. doi: 10.1001/archsurg.143.7.692.

PMID:
18645113
19.

Metastatic myoepithelial carcinoma of the vulva treated with carboplatin and paclitaxel.

Noronha V, Cooper DL, Higgins SA, Murren JR, Kluger HM.

Lancet Oncol. 2006 Mar;7(3):270-1. No abstract available.

PMID:
16510337
20.

Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.

Higgins SA, Matloff ET, Rimm DL, Dziura J, Haffty BG, King BL.

Breast Cancer Res. 2005;7(6):R1017-22. Epub 2005 Oct 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk